Table 3 Evaluation of the mast cell (MC) infiltrate and Synovitis score in the 60 osteoarthritis (OA) patients. SD: standard deviation; * significant differences with p < 0.05 in Knee and Hip groups
From: Synovial mast cells from knee and hip osteoarthritis: histological study and clinical correlations
Knee | Hip | |||
|---|---|---|---|---|
OA | Control | OA | Control | |
MCs /field (SD) [CI] * | 165.1 (76.88) [136.36–193.78] | 20 (5.92) [5.3–34.7] | 107.77 (23.55) [94.73–120.81] | 14 (2.74) [10.6–17.4] |
Area fraction (SD) (%) * | 0.65 (0.4) | 0.10 (0.09) | 0.31 (0.12) | 0.04 (0.02) |
Lining layer (SD) * | 1.58 (0.79) | 0.6 (0.42) | 1.2 (0.73) | 0.5 (0.45) |
Stromal activation (SD) * | 1.5 (0.52) | 0.2 (0.51) | 1.3 (0.62) | 0.4 (0.55) |
Infiltrate (SD) * | 1.41 (0.52) | 0.3 (0.43) | 1.27 (0.45) | 0.2 (0.45) |
Synovitis score (SD) * | 3.77 (1.55) | 0.4 (0.55) | 2.8 (0.92) | 0.6 (0.55) |
Vessel no. mean (SD), [IC95%] * | 59.48 (19) [52.25–66.71] | 25.2 (3.11) [21.33–29.07] | 54.44 (14.11) [47.42–61.46] | 16.4 (6.23) [8.67–24.13] |
Vessel area fraction (SD) (%) * | 6.3 (1.8) | 0.8 (0.3) | 3 (0.4) | 0.6 (0.3) |